2m 2m 2m 2m 2m 2m 2m
SUTRO BIOPHARMA (STRO)
NASDAQ
$10.26+$0.09 (+0.88%)
Price as of Nov 11, 2026 7:30 PM EST- $168.6MMarket Cap
- 25.08%1-Year Change
- BiotechnologyIndustry
SUTRO BIOPHARMA (STRO)
$10.26+$0.09 (+0.88%)
STRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.17 | ||
Change | -$0.44 (-4.15%) | ||
Open | $10.40 | ||
High | $10.77 | ||
Low | $9.94 | ||
Previous Close | $10.61 | ||
Volume | 217,227 | ||
30-Day Average Volume | 341,817 | ||
1-Week Change | 6.94% | ||
1-Month Change | -28.73% | ||
1-Year Change | 25.08% | ||
3-Year Change | -51.11% | ||
5-Year Change | -95.29% | ||
Fundamentals | |||
Shares Outstanding | 16.6M | ||
Total Assets | $194.5M | ||
Market Cap | $168.6M | ||
Enterprise Value | $114.3M | ||
Period: QTR TTM FY | |||
Revenue | $9.8M | ||
Net Income | -$38.5M | ||
Free Cash Flow | -$38.3M | ||
EBIT | -$38.5M | ||
EBITDA | -$37.3M | ||
Net Working Capital | $122.7M | ||
EPS | -$2.33 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 12 | ||
P/B | -2 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/03/2025 | ||
Earnings & Revenue